Current Month 2005
Article Features
  New Technique Reduces Side Effects for Breast Cancer Patients
Breast-Conserving Surgery Underused in Asian and Pacific Island Women
One in Five Women Would Consider Breast Removal to Reduce Their Risk of Cancer
Poll Finds Many Americans Believe Cancer Myths
Medicare Claims Accurately Reflect Chemotherapy Use in Elderly Beneficiaries
Study Questions Success of Breast Cancer Screening Programs in Community Settings
Researchers Discover Molecular Pathway That Leads to Breast Cancer
Women Want More Information When Considering Their First Mammogram
Subtle Changes in Normal Genes Implicated in Breast Cancer
Gene Found in 90 Percent of Breast Cancers May be Cancer Vaccine Target
Breast Cancer Growth Regulator Holds Promise for More Targeted Treatment
Breast Cancer Patients Cautioned Against Using Herbal Supplements
New Study Examines Characteristics of Women with Inflammatory Breast Cancer
Higher Urinary Melatonin Levels May Be Associated With Lower Breast Cancer Risk
Patient Navigation Programs in Cancer Clinics
Early Trial of Cancer Drug Shows Promise
Study Identifies Risks with Over-the-Counter Progesterone
Anti-Cancer Drug Targets Tumors with Akt Protein
Risks Outweigh Benefits of Shark Cartilage as Anti-Cancer Treatment
Decreased Breast Cancer Survival Associated with High TRAIL-R2 Expression


Benign Breast Disease an Important Breast Cancer Risk Factor

A study led by the Mayo Clinic Cancer Center adds evidence to a growing body of knowledge that shows women with benign breast disease have a higher risk for breast cancer, and that certain types of breast disease may predict the near-term development of breast cancer. The findings were published in The New England Journal of Medicine.

"Our findings indicate a link between select types of benign breast lesions and the later development of breast cancer," says Lynn Hartmann, M.D., Mayo Clinic oncologist and lead investigator of the study. "Women who have a breast biopsy that is benign must discuss the possibility of additional risks with their doctors."

Benign breast disease refers to any lumps or mammographically-detected abnormalities that have been biopsied and found to not contain cancerous cells. Each year in the United States it is estimated that more than 1 million women have a breast biopsy with benign findings, and Hartmann encourages clinicians to look more closely at the type of lesions they find. The Mayo team is evaluating various possible risk factors for a later breast cancer, including age at benign biopsy, family history of breast cancer and the pathologic findings of the benign lesion. "Our goal is to do a better job of risk prediction for women with various types of benign breast conditions," says Hartmann.

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon